Medtronic plc Quarterly Stockholders' Equity Attributable to Parent in USD from Q1 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
Medtronic plc quarterly Stockholders' Equity Attributable to Parent history and growth rate from Q1 2012 to Q2 2024.
  • Medtronic plc Stockholders' Equity Attributable to Parent for the quarter ending July 26, 2024 was $47.9B, a 6.31% decline year-over-year.
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $47.9B -$3.23B -6.31% Jul 26, 2024 10-Q 2024-08-27
Q1 2024 $50.2B -$1.27B -2.47% Apr 26, 2024 10-Q 2024-08-27
Q4 2023 $51.8B +$351M +0.68% Jan 26, 2024 10-Q 2024-02-27
Q3 2023 $51.5B -$420M -0.81% Oct 27, 2023 10-Q 2023-11-30
Q2 2023 $51.2B -$1.49B -2.84% Jul 28, 2023 10-Q 2023-08-31
Q1 2023 $51.5B -$1.07B -2.03% Apr 28, 2023 10-K 2024-06-20
Q4 2022 $51.4B -$1.1B -2.1% Jan 27, 2023 10-Q 2023-03-01
Q3 2022 $51.9B -$111M -0.21% Oct 28, 2022 10-Q 2022-12-01
Q2 2022 $52.7B +$1.19B +2.3% Jul 29, 2022 10-Q 2022-09-01
Q1 2022 $52.6B +$1.12B +2.18% Apr 29, 2022 10-K 2023-06-22
Q4 2021 $52.5B +$1.78B +3.52% Jan 28, 2022 10-Q 2022-03-03
Q3 2021 $52B +$1.83B +3.64% Oct 29, 2021 10-Q 2021-12-02
Q2 2021 $51.5B +$1.19B +2.37% Jul 30, 2021 10-Q 2021-09-02
Q1 2021 $51.4B +$691M +1.36% Apr 30, 2021 10-K 2022-06-23
Q4 2020 $50.8B -$1.05B -2.03% Jan 29, 2021 10-Q 2021-03-05
Q3 2020 $50.2B -$414M -0.82% Oct 30, 2020 10-Q 2020-12-03
Q2 2020 $50.3B -$67M -0.13% Jul 31, 2020 10-Q 2020-09-03
Q1 2020 $50.7B +$646M +1.29% Apr 24, 2020 10-K 2021-06-25
Q4 2019 $51.8B +$1.98B +3.97% Jan 24, 2020 10-Q 2020-02-28
Q3 2019 $50.6B +$971M +1.96% Oct 25, 2019 10-Q 2019-12-03
Q2 2019 $50.4B +$139M +0.28% Jul 26, 2019 10-Q 2019-08-30
Q1 2019 $50.1B -$629M -1.24% Apr 26, 2019 10-K 2020-06-19
Q4 2018 $49.8B -$405M -0.81% Jan 25, 2019 10-Q 2019-03-01
Q3 2018 $49.6B -$1.86B -3.62% Oct 26, 2018 10-Q 2018-11-29
Q2 2018 $50.2B -$448M -0.88% Jul 27, 2018 10-Q 2018-08-31
Q1 2018 $50.7B +$512M +1.02% Apr 27, 2018 10-K 2019-06-21
Q4 2017 $50.2B +$847M +1.72% Jan 26, 2018 10-Q 2018-03-02
Q3 2017 $51.5B +$1.28B +2.56% Oct 27, 2017 10-Q 2017-12-04
Q2 2017 $50.7B -$152M -0.3% Jul 28, 2017 10-Q 2017-09-01
Q1 2017 $50.2B -$1.86B -3.56% Apr 28, 2017 10-K 2018-06-22
Q4 2016 $49.4B -$1.43B -2.81% Jan 27, 2017 10-Q 2017-03-03
Q3 2016 $50.2B -$2.08B -3.99% Oct 28, 2016 10-Q 2016-12-05
Q2 2016 $50.8B -$1.99B -3.76% Jul 29, 2016 10-Q 2016-09-07
Q1 2016 $52.1B -$1.17B -2.19% Apr 29, 2016 10-K 2017-06-27
Q4 2015 $50.8B +$50.9B Jan 29, 2016 10-Q 2016-03-09
Q3 2015 $52.3B Oct 30, 2015 10-Q 2015-12-09
Q2 2015 $52.8B Jul 31, 2015 10-Q 2015-09-09
Q1 2015 $53.2B +$33.8B +174% Apr 24, 2015 10-K 2016-06-28
Q4 2014 -$37M* Jan 23, 2015 10-Q 2015-02-27
Q1 2014 $19.4B +$772M +4.14% Apr 25, 2014 10-K 2016-06-28
Q1 2013 $18.7B +$1.56B +9.1% Apr 26, 2013 10-K 2016-06-28
Q1 2012 $17.1B Apr 27, 2012 10-K 2015-06-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.